Youngbo Chemical Q1 2026: Sales Up, Operating Profit and Net Income Down

Sales: KRW 28.3B (+7.45% YoY), Operating profit: KRW 3.1B (-8.60% YoY), Pre-tax profit: KRW 4.5B (+10.57% YoY), Net income: KRW 3.1B (-11.03% YoY)
Chinese subsidiary recorded a loss of KRW 0.8B in Q1 (vs profit of KRW 0.3B in prior year)
Debt ratio: 0% (net cash position of KRW 7.4B, cash & equivalents KRW 12.2B)
Credit rating: A- (NICE, unchanged for 3 years)
Dividend: KRW 350 per share (final for previous year), total payout KRW 6.8B
One pending lawsuit (KRW 70M, considered immaterial)
Treasury shares: 500,000 shares (no change)